Maeve Cullinan is a reporter for The Telegraph’s Global Health Security desk. She covers issues including disease outbreaks, conflict, global development, humanitarian crises, and sexual violence and has reported from Africa and Asia. She was named on the Press 30 under 30 list in 2025.
Published 22 October 2026 11:25am BST Maeve Cullinan Global Health Security Reporter Show biographyMaeve Cullinan is a reporter for The Telegraph’s Global Health Security desk. She covers issues including disease outbreaks, conflict, global development, humanitarian crises, and sexual violence and has reported from Africa and Asia. She was named on the Press 30 under 30 list in 2025.
Published 22 October 2026 11:25am BSTHuge strides have been made in recent years in combating malaria but one group is more at risk than ever before: pregnant women.
They are uniquely vulnerable to the disease and because sub-Saharan Africa shoulders the burden of global cases the continent’s rapidly growing population means far more women are exposed today than at the turn of the millennium.
According to a recent study, 52 million pregnant women in Africa face the threat of malaria each year, up from 37 million in 2000.
And the toll is heavy: malaria in pregnancy kills at least 10,000 mothers and 210,000 infants every year.
Malaria in pregnancy is uniquely dangerous, and the disease acts very differently to how it does in someone who is not pregnant.
“Pregnant women are one of the most vulnerable groups to malaria, it can lead to severe anaemia, immune suppression, and in the worst cases, mortality,” Lottie Renwick, global campaign director at Malaria No More UK told The Telegraph.
Malaria parasites infect and feed on red blood cells, dividing and multiplying in the bloodstream. This makes them easily detectable through a simple blood test, which allows life-saving treatment to be administered quickly.
But in pregnancy, the parasites are notoriously evasive.
Instead of floating in the bloodstream, they colonise in the placenta – the organ that feeds and sustains the baby.
Malaria in pregnancy is uniquely dangerous Credit: Abbie Trayler-Smith“Why? Because in a pregnant woman that is the primary source of really good oxygenated blood,” Dr Matthew Chico, an infectious disease epidemiologist at the London School of Hygiene and Tropical Medicine, told The Telegraph.
This means a blood test of a mother more often than not comes back negative, even when her placenta is riddled with parasites.
Estimates suggest as many as 70 per cent of cases in pregnant women are missed for this reason.
The consequences of untreated malaria for mother and baby can be severe.
“A placenta impaired with malaria doesn’t function as it should,” said Dr Chico. “You will end up having a small baby, low birth weight, much smaller than normally would have been the case.”
The parasites restrict the flow of oxygen and vital nutrients to the baby, often for long stretches of a pregnancy before the infection is detected. And the consequences can be lifelong.
“A child who is born with low birth weight has less biological resources, the kind of resources you need to endure the earliest days of life outside of the womb,” said Dr Chico.
“Most deaths worldwide occur among newborns on that first day of life. When a child is delivered, he or she will always naturally lose weight because they aren’t getting nutrients through the umbilical cord.
“They have to suckle from their mothers, and they have to strengthen that suckling response over time, and a mother doesn’t produce milk in large quantities at first.
“So if you are already starting with a deficiency at birth, you can go down a downward spiral, especially if you get another infection post-birth.”
Mothers wait for their sick babies to receive treatment at a malaria clinic in Malawi Credit: AFP/Getty Images/AMOS GUMULIRASome babies do not make it to delivery, either.
Of all stillbirths in Africa, 20 per cent are estimated to be caused by an active malaria infection in the mother, equivalent to 120,000 children.
A critical problem, experts say, is not only that malaria in pregnancy is difficult to diagnose, but that many infected women feel perfectly well, unaware of what is going on inside their body.
In parts of Africa where malaria is endemic, people are often infected periodically throughout their lives, and frequently in childhood, and are able to build robust immunity.
It means if they are infected as adults, they can keep the disease at bay without feeling unwell.
As a result, a woman can carry malaria in her blood for years, in low levels, and never realise. This is a very useful biological mechanism – until she becomes pregnant.
As her immune system becomes more vulnerable, the parasites that were previously kept at bay begin to multiply and spread.
“By design, when a woman is pregnant, her immune system becomes less aggressive to foreign entities, because half of the DNA of the foetus is from the father, and so if her immune system were to operate normally, that would put the foetus at risk,” said Dr Chico.
Yet while she may still feel well, the parasites can spread unchecked through her body and can lead to anaemia.
Maternal anaemia is linked to a host of problems, from having a baby with a low birthweight to giving birth preterm. But the biggest threat to the woman is postpartum haemorrhage.
“The parasites feed on haemoglobin that is there in the red blood cells. It’s what carries oxygen to our muscles, and aids in muscle contractions, which is obviously part of delivering a baby,” said Dr Chico.
Contractions not only help to push out a baby, they also help to stop the bleeding afterwards.
“You’re bleeding, which is a natural consequence of childbirth. The placenta detaches, and you deliver the placenta, you deliver the baby, and there’s more bleeding.
“But then you’re meant to have contractions that start at the top of the cervix, and those contractions are designed to act like a stent to stop the blood loss,” said Dr Chico.
Studies have shown that women with an active malaria infection have 3-fold higher odds of developing postpartum haemorrhage, defined as roughly 500 millilitres of blood loss in the 24 hours following delivery.
“This is where the [malaria-related] maternal deaths most often come,” said Dr Chico.
Haemorrhage linked to maternal anaemia is thought to be responsible for the vast majority of the 10,000 annual maternal deaths from malaria.
Recommended
How Suriname eliminated malaria – and what others can learn from it Read moreThe World Health Organization (WHO) has been scrambling for decades to find life-saving solutions that might help bring down the burden of malaria for pregnant women and their babies.
“Clinical trials often exclude pregnant women, and that makes it really difficult to develop the right kind of drugs and tools needed to be able to treat them effectively,” said Ms Renwick of Malaria No More.
For women who do test positive for malaria during their pregnancies, treatment options are often limited given safety concerns, particularly during the first trimester.
In the most at-risk countries, places like Nigeria, Kenya, Ghana, and the Democratic Republic of the Congo, all pregnant women are now given three doses of preventive malaria treatment, spaced between their antenatal appointments.
“We don’t have to be really passive about women who may have a malaria infection and become sick and require treatment,” Dr Chico said.
“There is a better way, and that is providing preventive treatment to all women in their second and third trimester. Ideally, women would come monthly. But that’s not always the case.”
However, only a third of women eligible for malaria prophylaxis currently receive it.
Women living in remote and rural areas, displacement camps, and conflict zones are the most likely to miss out on life-saving treatment, where access to critical healthcare is more precious, and pregnant women often face a severe lack of access to adequate antenatal care.
The problem has been exacerbated by what experts call malaria’s “perfect storm”: a combination of climate change pushing mosquitoes into new areas, global aid cuts which have threatened elimination programmes, and rising drug-resistance that makes the parasites more able to resist the medicine designed to kill them.
And while vaccines against malaria were made available for the first time in history 2024, they are not yet licenced for use in adults, and have only been used in young children under five.
Medicines for Malaria Venture, a foundation established in the 1990s to develop products against the disease, has recently launched a strategy in partnership with the Liverpool School for Tropical Medicine to bridge the “critical data gap” on antimalarial safety and dosage for pregnant and lactating women.
By 2030, they hope to have helped to fund and develop a new treatment that can safely be used by pregnant women during the first trimester.
“We are starting to make some progress to start to expand the reach and scope of options for pregnant women,” said Ms Renwick.
Protect yourself and your family by learning more about Global Health Security
More from News
-
Sophie Winkleman and Lord Frederick Windsor take over Duchess of Kent’s music charity
-
Book clubs benefit the mind as much as meditation, Queen’s charity finds
-
I’m a Labour MP – here are 12 reasons we should not rejoin the EU
-
Trans law would put parents at risk, says family court expert
-
Leading Labour ‘rejoiner’ backs Swiss-style relationship with EU
-
Knife offenders avoid jail in record numbers after Labour reforms